Ignite Creation Date:
2024-07-17 @ 10:52 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06478719
Status:
RECRUITING
Last Update Posted:
2024-06-27
First Post:
2024-06-17
Brief Title:
To Evaluate Safety and Efficacy of FB-1603 in Hepatocellular Carcinoma Patient Receiving Transarterial Chemoembolization
Sponsor:
Febico Biomedical Corp
Organization:
Febico Biomedical Corp
Organization Data
Organization:
Febico Biomedical Corp
Class:
INDUSTRY
Study ID:
FB-1603_TACE_PII_2022_1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Febico Biomedical Corp
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Taiwan University Hospital | OTHER |